Moon D
Int J Mol Sci. 2024; 25(5).
PMID: 38474160
PMC: 10932100.
DOI: 10.3390/ijms25052911.
Park A, Leney-Greene M, Lynberg M, Gabrielski J, Xu X, Schwarz B
Nat Immunol. 2024; 25(2):282-293.
PMID: 38172257
PMC: 11151279.
DOI: 10.1038/s41590-023-01691-y.
Montenarh M, Gotz C
Cells. 2023; 12(24).
PMID: 38132153
PMC: 10741536.
DOI: 10.3390/cells12242834.
Medley J, Yim R, DiPanni J, Sebou B, Shaffou B, Cramer E
iScience. 2023; 26(12):108410.
PMID: 38034351
PMC: 10687292.
DOI: 10.1016/j.isci.2023.108410.
Fux J, Lefort E, Rao P, Blay J
Front Pharmacol. 2023; 13:1086894.
PMID: 36618939
PMC: 9815539.
DOI: 10.3389/fphar.2022.1086894.
Protein Kinase CK2 Contributes to Glucose Homeostasis by Targeting Fructose-1,6-Bisphosphatase 1.
Pack M, Gulde T, Volcker M, Boewe A, Wrublewsky S, Ampofo E
Int J Mol Sci. 2023; 24(1).
PMID: 36613872
PMC: 9820633.
DOI: 10.3390/ijms24010428.
Minor Kinases with Major Roles in Cytokinesis Regulation.
Sechi S, Piergentili R, Giansanti M
Cells. 2022; 11(22).
PMID: 36429067
PMC: 9688779.
DOI: 10.3390/cells11223639.
CK2 and the Hallmarks of Cancer.
Firnau M, Brieger A
Biomedicines. 2022; 10(8).
PMID: 36009534
PMC: 9405757.
DOI: 10.3390/biomedicines10081987.
Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization.
Marshall C, McBride J, Changolkar L, Riddle D, Trojanowski J, Lee V
Acta Neuropathol Commun. 2022; 10(1):30.
PMID: 35246269
PMC: 8895919.
DOI: 10.1186/s40478-022-01331-w.
SGC-CK2-1 Is an Efficient Inducer of Insulin Production and Secretion in Pancreatic β-Cells.
Pack M, Gotz C, Wrublewsky S, Montenarh M
Pharmaceutics. 2022; 14(1).
PMID: 35056914
PMC: 8778508.
DOI: 10.3390/pharmaceutics14010019.
CSNK2 in cancer: pathophysiology and translational applications.
Strum S, Gyenis L, Litchfield D
Br J Cancer. 2021; 126(7):994-1003.
PMID: 34773100
PMC: 8980014.
DOI: 10.1038/s41416-021-01616-2.
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300.
Rosales M, Perez G, Ramon A, Cruz Y, Rodriguez-Ulloa A, Besada V
Biomedicines. 2021; 9(7).
PMID: 34356831
PMC: 8301452.
DOI: 10.3390/biomedicines9070766.
Dysregulation of phosphoproteins in hepatocellular carcinoma revealed via quantitative analysis of the phosphoproteome.
Liu Y, Zhao Q, Xu F, Wang K, Zhao Y, Chen H
Oncol Lett. 2021; 21(2):117.
PMID: 33408763
PMC: 7779902.
DOI: 10.3892/ol.2020.12378.
Apigenin upregulation of CD26/DPPIV on colon epithelial cells requires inhibition of casein kinase 2.
Lefort E, Diaconu B, Bentley V, Blay J
Food Sci Nutr. 2020; 8(10):5321-5329.
PMID: 33133535
PMC: 7590318.
DOI: 10.1002/fsn3.1823.
Hyperphosphorylation of fetal liver IGFBP-1 precedes slowing of fetal growth in nutrient-restricted baboons and may be a mechanism underlying IUGR.
Kakadia J, Jain B, Biggar K, Sutherland A, Nygard K, Li C
Am J Physiol Endocrinol Metab. 2020; 319(3):E614-E628.
PMID: 32744097
PMC: 7642856.
DOI: 10.1152/ajpendo.00220.2020.
Protein Kinase CK2 in Cancer Energetics.
Silva-Pavez E, Tapia J
Front Oncol. 2020; 10:893.
PMID: 32626654
PMC: 7315807.
DOI: 10.3389/fonc.2020.00893.
Crystal structure of Arabidopsis thaliana casein kinase 2 α1.
Demulder M, De Veylder L, Loris R
Acta Crystallogr F Struct Biol Commun. 2020; 76(Pt 4):182-191.
PMID: 32254052
PMC: 7137383.
DOI: 10.1107/S2053230X20004537.
Cellular signaling and epigenetic regulation of gene expression in leukemia.
Gowda C, Song C, Ding Y, Iyer S, Dhanyamraju P, McGrath M
Adv Biol Regul. 2019; 75:100665.
PMID: 31623972
PMC: 7239353.
DOI: 10.1016/j.jbior.2019.100665.
Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity.
Salizzato V, Zanin S, Borgo C, Lidron E, Salvi M, Rizzuto R
FASEB J. 2019; 33(10):10648-10667.
PMID: 31268746
PMC: 6766657.
DOI: 10.1096/fj.201801833RR.
Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management.
Lian H, Su M, Zhu Y, Zhou Y, Soomro S, Fu H
Asian Pac J Cancer Prev. 2019; 20(1):23-32.
PMID: 30677865
PMC: 6485562.
DOI: 10.31557/APJCP.2019.20.1.23.